Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
renal disease
MedTech
Revivicor sees 61 days' function in kidney+thymus xenotransplant
United Therapeutics' Revivicor division is eyeing human clinical trials in 2025 of its manufactured organs derived from genetically modified pigs.
Conor Hale
Sep 25, 2023 9:45am
Racing Bayer, Merck gets FDA fast-track tag for anticoagulant
Aug 23, 2022 8:40am
Bayer-Ionis' anti-thrombotic med doesn't increase bleeding
Jul 28, 2022 10:51am
Sanifit lands $231M Vifor buyout ahead of phase 3 data
Nov 22, 2021 6:08am
Everest inks $561M biobucks deal for renal disease treatment
Sep 17, 2021 10:20am
FDA clears Baxter's connected, in-center dialysis machine
Mar 12, 2021 10:59am